ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Turnstone Biologics Corporation

Turnstone Biologics Corporation (TSBX)

0.467
0.00
(0.00%)
Closed 15 January 8:00AM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.467
Bid
0.47
Offer
0.507
Volume
-
0.00 Day's Range 0.00
0.403 52 Week Range 5.75
Market Cap
Previous Close
0.467
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
293,963
Shares Outstanding
23,128,454
Dividend Yield
-
PE Ratio
-0.20
Earnings Per Share (EPS)
-2.39
Revenue
19.31M
Net Profit
-55.2M

About Turnstone Biologics Corporation

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient's tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
La Jolla, California, USA
Founded
-
Turnstone Biologics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSBX. The last closing price for Turnstone Biologics was US$0.47. Over the last year, Turnstone Biologics shares have traded in a share price range of US$ 0.403 to US$ 5.75.

Turnstone Biologics currently has 23,128,454 shares in issue. The market capitalisation of Turnstone Biologics is US$10.80 million. Turnstone Biologics has a price to earnings ratio (PE ratio) of -0.20.

TSBX Latest News

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach...

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Turnstone’s next-generation Selected TIL technology is designed to selectively expand the most potent tumor-reactive T cells for treatment of solid tumors Results further support the continued...

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

Realigning resources to focus on clinical advancement of Selected TIL therapyReducing employee headcount by approximately 60%Streamlining operations with cash runway expected to extend into 2Q...

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Announced positive initial data from Phase 1 trial of TIDAL-01 in metastatic colorectal cancer including a complete response in one of the four patients reported Cash position expected to fund...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0564-10.77569736340.52340.55980.45071639600.4827511CS
4-0.01835-3.780776759040.485350.62320.43131550050.53153338CS
12-0.064-12.05273069680.5310.69670.4032939630.5369142CS
26-2.073-81.61417322832.542.690.4032631080.71442796CS
52-1.683-78.27906976742.155.750.4032178331.58152496CS
156-10.933-95.903508771911.413.20.4031745252.15174932CS
260-10.933-95.903508771911.413.20.4031745252.15174932CS

TSBX - Frequently Asked Questions (FAQ)

What is the current Turnstone Biologics share price?
The current share price of Turnstone Biologics is US$ 0.467
How many Turnstone Biologics shares are in issue?
Turnstone Biologics has 23,128,454 shares in issue
What is the market cap of Turnstone Biologics?
The market capitalisation of Turnstone Biologics is USD 10.8M
What is the 1 year trading range for Turnstone Biologics share price?
Turnstone Biologics has traded in the range of US$ 0.403 to US$ 5.75 during the past year
What is the PE ratio of Turnstone Biologics?
The price to earnings ratio of Turnstone Biologics is -0.2
What is the cash to sales ratio of Turnstone Biologics?
The cash to sales ratio of Turnstone Biologics is 0.56
What is the reporting currency for Turnstone Biologics?
Turnstone Biologics reports financial results in USD
What is the latest annual turnover for Turnstone Biologics?
The latest annual turnover of Turnstone Biologics is USD 19.31M
What is the latest annual profit for Turnstone Biologics?
The latest annual profit of Turnstone Biologics is USD -55.2M
What is the registered address of Turnstone Biologics?
The registered address for Turnstone Biologics is 9310 ATHENA CIRCLE, SUITE 300, LA JOLLA, CALIFORNIA, 92037
Which industry sector does Turnstone Biologics operate in?
Turnstone Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0

TSBX Discussion

View Posts
jondoeuk jondoeuk 3 months ago
60% RIF (cash into 2026) https://www.oncologypipeline.com/apexonco/no-easy-ride-turnstone
👍️0
Stock Shakers Stock Shakers 5 months ago
https://www.tipranks.com/stocks/tsbx/forecast
👍️0
Monksdream Monksdream 5 months ago
TSBX new 52+week low
👍️0
jondoeuk jondoeuk 5 months ago
I assume (rightly or wrongly) it is down as they were supposed to have shared data on ~20-30 patients. There was also no conference call and they cut two indications (I agree with melanoma). Data shows promise, but you have to show the market more than that.

https://finance.yahoo.com/news/turnstone-biologics-corp-reports-positive-200100662.html
👍️0
Monksdream Monksdream 6 months ago
TSBX under $3
👍️0
Monksdream Monksdream 6 months ago
TSBX under $3
👍️0
stock1ace1 stock1ace1 7 months ago
$3.02
👍️0
stock1ace1 stock1ace1 7 months ago
$2.94 buys coming in
👍️0
stock1ace1 stock1ace1 7 months ago
Tsbx -> We remain on track and plan to provide a TIDAL-01 clinical update mid-year in connection with our next quarterly financial results.”
👍️0
stock1ace1 stock1ace1 7 months ago
$3.00s (200ma break) #Bullish
👍️0
stock1ace1 stock1ace1 7 months ago
Tsbx $2.99 Pending data look at chart -> https://schrts.co/JiDydKgr
👍️0
Monksdream Monksdream 8 months ago
TSBX under $3
👍️0
jondoeuk jondoeuk 8 months ago
CEO saying data in July-August.
👍️0
Monksdream Monksdream 9 months ago
TSBX under $3
👍️0
Laster Laster 9 months ago
Nice biotech company. Looks like it wants to break out past $3.50.
I think it has a lot more to run,
JMO.
👍️0
TrendTrade2016 TrendTrade2016 11 months ago
TSBX....here we go...monster bio
👍️0
TrendTrade2016 TrendTrade2016 11 months ago
TSBX...MONSTER BIO BEAST IS READY TO BLOW UP
👍️0
jondoeuk jondoeuk 11 months ago
What was?
👍️0
Awl416 Awl416 1 year ago
That was quick
👍️0
jondoeuk jondoeuk 1 year ago
https://twitter.com/jitcancer/status/1710328085151727650
👍️0
jondoeuk jondoeuk 1 year ago
Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html
👍️0

Your Recent History

Delayed Upgrade Clock